University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Use of Tissue Oxygen Monitoring in Critically Injured Patients

Terminated

Conditions: Hemorrhagic Shock
Traumatic Brain Injury
Trauma

First Posted Date: 2006-05-19

Last Posted Date: 2013-09-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 67

Registration Number: NCT00328341

Locations: 🇺🇸
University of California San Francisco, San Francisco General Hospital, San Francisco, California, United States

Intensive Glycemic Control and Skeletal Health Study

Phase 3

Completed

Conditions: Atherosclerosis
Cardiovascular Diseases
Hypercholesterolemia
Hypertension
Diabetes Mellitus
Coronary Disease

Interventions: Drug: hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents

First Posted Date: 2006-05-11

Last Posted Date: 2012-10-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 7287

Registration Number: NCT00324350

Locations: 🇺🇸
Berman Center for Outcomes & Clinical Research, Minneapolis, Minnesota, United States
🇨🇦
Population Health Research Institute, Hamilton, Ontario, Canada
🇺🇸
Wake Forest University, Winston-Salem, North Carolina, United States

and more 2 locations

Trachoma Amelioration in Northern Amhara (TANA)

Phase 4

Completed

Conditions: Trachoma
Chlamydia

Interventions: Drug: Mass treatment with oral azithromycin to an entire community

First Posted Date: 2006-05-09

Last Posted Date: 2015-09-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 33000

Registration Number: NCT00322972

Locations: 🇪🇹
Carter Center, Ethiopia, Addis Ababa, Ethiopia

Impact of Using Mini-Bronchoalveolar Lavage as a Diagnostic Test for Ventilator-Associated Pneumonia

Not Applicable

Completed

Conditions: Ventilator-Associated Pneumonia

Interventions: Device: Bronchoalveolar lavage

First Posted Date: 2006-04-27

Last Posted Date: 2012-11-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 37

Registration Number: NCT00319644

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

Heart and Estrogen-Progestin Replacement Study (HERS)

Phase 3

Completed

Conditions: Coronary Heart Disease

First Posted Date: 2006-04-27

Last Posted Date: 2006-04-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 2430

Registration Number: NCT00319566

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules

Not Applicable

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2006-04-21

Last Posted Date: 2014-02-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 400

Registration Number: NCT00316823

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Lung Cancer
Esophageal Cancer
Extragonadal Germ Cell Tumor
Bladder Cancer
Ovarian Cancer
Prostate Cancer
Brain and Central Nervous System Tumors
Breast Cancer
Gastric Cancer

Interventions: Drug: lapatinib
Drug: paclitaxel

First Posted Date: 2006-04-12

Last Posted Date: 2014-07-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 28

Registration Number: NCT00313599

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Temozolomide in Treating Patients With Low-Grade Glioma

Phase 2

Completed

Conditions: CNS Tumor, Adult

Interventions: Drug: temozolomide

First Posted Date: 2006-04-12

Last Posted Date: 2019-02-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 120

Registration Number: NCT00313729

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer

Phase 1

Terminated

Conditions: Prostate Cancer

First Posted Date: 2006-04-12

Last Posted Date: 2012-10-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 15

Registration Number: NCT00313534

Locations: 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States

Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia

Phase 1

Completed

Conditions: Schizophrenia

Interventions: Behavioral: Computer games
Behavioral: Targeted cognitive training (TCT)

First Posted Date: 2006-04-11

Last Posted Date: 2014-03-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80

Registration Number: NCT00312962

Locations: 🇺🇸
San Francisco Department of Veterans Affairs Medical Center, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy